HSP90B1 and neoplasm: The fact that the expression on cell surface and even the secretion of Grp94 can only occur in malignant but not normal cells, offers the unique opportunity to specifically target the protein to halt the tumor progression in a much safer manner compared to the conventional anti-cancer therapy.